Our Mission

We exist to help prevent stroke, save lives, and give physicians and patients the confidence to choose carotid stenting — without compromise.

Headquartered in Miami, FL we’re leading a global effort to transform carotid artery intervention. With an established international footprint and a relentless focus on innovation, we’re advancing stroke prevention everywhere it’s needed.

Stroke prevention isn't an afterthought — it's our blueprint.

With smarter design and unmatched data, we protect against carotid plaque prolapse and deliver peace of mind with our next-gen, flagship product, CGuard^® Prime — a new layer of defense.

CGuard Prime

CGuard Prime is the next generation of carotid stenting, featuring a unique dual-layer design with a finely woven MicroNet™ mesh covering—taking stroke prevention to a new level. CGuard Prime demonstrated the lowest independently adjudicated 30-day and 1-year primary endpoint major adverse event rates of any pivotal study of carotid intervention. ^1-10

💡CGuard Prime is the only FDA approved mesh-covered carotid stent

---

1. InspireMD, Inc. C-GUARDIANS Pivotal Trial: Primary Endpoint Clinical Study Report. Version F (Protocol PRO-9017)
2. Yadav JS, et al. N Engl J Med. 2004 Oct;351(15):1493-1501. doi:10.1056/NEJMoa040127
3. Matsumura JS, et al. J Vasc Surg. 2012 Apr;55(4):968-76. doi:10.1016/j.jvs.2011.10.120
4. Higashida R, et al. Stroke vol. 41,2 (2010): e102-9. doi: 10.1161/STROKEAHA.109.564161
5. Brott TG, et al. N Engl J Med. 2010 Jul;363(1):11-23. doi: 10.1056/NEJMoa0912321. Epub 2010 May 26
6. Kwolek CJ, et al. J Vasc Surg. 2015 Nov;62(5):1227-34.doi:10.1016/j.jvs.2015.04.460
7. U.S. Food and Drug Administration. Summary of safety and effectiveness data (SSED): Roadsaver/CASPER Carotid Stent System (PMA P210030). Published November 20, 2024
8. Gray WA, et al. J Am Coll Cardiol Intv. 2025 Feb;18(3):367-76. doi:10.1016/j.jcin.2024.10.031
9. Safian RD, et al. J Am Coll Cardiol. 2006 Jun;47(12):2384-89. doi:10.1016/j.jacc.2005.12.076
10. Langhoff R, et al. Cardiovasc Intervent Radiol. 2025 Mar;Vol 48 427–37. doi: 10.1007/s00270-025-04003-z